SOLV - Rasio rega marang pendapatan Solventum Corp

Tandha merek Solventum Health (SOLV)

This P/S ratio chart illustrates the asset's dynamics as Solventum Corporation (SOLV) implements smart materials and clinic software. 1.90 indicates the current valuation level. High barriers to entry provide protection due to stringent FDA regulations and lobbying. Brian Hanson aims to reduce debt and optimize expenses following the spin-off of Solventum Corporation (SOLV) from the conglomerate to accelerate growth.

SOLV Rasio rega marang pendapatan Solventum Corp (01.03.2025 - 13.11.2026)

Solventum Inc. (SOLV) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:SOLV (solventum.com)
Produk merek Solventum Inc.

The stable revenue stream of Solventum Corporation (SOLV) from medical technology and dentistry following its spin-off from 3M allows for the assessment of the business's market value relative to its actual sales via the P/S ratio. By analyzing the industry-average P/S of the company on the GURU.Markets platform, an investor can determine the asset's degree of overheating and identify safe entry points where capitalization is balanced with the enterprise's operational turnover.

Karo sapa Solventum Corporation saingan

Rasio rega marang pendapatan HCA (hcahealthcare.com)|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Fresenius Medical Care AG - Rasio rega marang pendapatan|Encompass Health Inc. - Multiplikator P/S|Rega marang dodolan Universal Health Services|DaVita Inc. (DVA) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan RDNT|Kapitalisasi marang pendapatan OPCH|SGRY (Surgery Partners Inc) - Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan PINC (Premier Corp)|Multiplikator P/S America's Best Contacts & Eyeglasses (EYE)|Rasio rega marang pendapatan Progyny, Inc. PGNY|ARDT - Kapitalisasi marang pendapatan|SEM: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan ASTH (Astrana Health Inc)|MD: Multiplikator P/S|Kapitalisasi marang pendapatan U.S. Physical Therapy, Inc.|Rasio rega marang pendapatan The Pennant Group, Inc.|Rega marang dodolan organogenesis.com ORGO|Rasio rega marang pendapatan Nutex Health (NUTX)|AUNA (Auna S.A.) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan SBC Medical Group Holdings Inc. SBC|EOLS (Evolus Corp) - Rasio rega marang dodolan|CYH - Rasio rega marang pendapatan|Rega marang dodolan The Beauty Health|mediwound.com (MDWD) - Rasio rega marang pendapatan|Biote - Rasio kapitalisasi pasar marang pendapatan|JYNT (The Joint Corporation) - Multiplikator P/S|Multiplikator P/S DocGo, Inc|Kapitalisasi marang pendapatan PIII (P3 Health Partners Inc.)|Kapitalisasi marang volume dodolan GANX|Multiplikator P/S EUDA (EUDA Health Holdings Limited)|Koefisien rega marang pendapatan Basel Medical (BMGL)|CLGN - Rasio rega marang pendapatan|Rega marang dodolan Cuprina Holdings Limited|Concord Medical Services (CCM) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan AMS|Rasio rega marang pendapatan MEDIROM Healthcare Group|Avalon GloboCare Corporation (ALBT) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan DIH Holding US Inc. (DHAI)|XAGE - Rega marang dodolan|Rasio rega marang pendapatan NewGenIvf Group Limited NIVF|ATI Physical Therapy Inc. - Rasio rega marang pendapatan|CMAX: Kapitalisasi marang pendapatan|KDLY: Rasio rega marang pendapatan|MODV (LogistiCare) - Kapitalisasi marang pendapatan|NVOS: Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan SunLink Health Systems Inc.|BACK: Rasio kapitalisasi pasar marang pendapatan